Lynn A. Tetrault, Director at NEOGENOMICS INC (NEO), sold 5,000 shares at $16.16 ($81K) on 2018-11-14, disclosed to the SEC on 2018-11-16.
Open-market sale of $81k NEO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NEO | SELL | 2026-06-11 | $60K | — | Filing → |
| NEO | BUY | 2025-05-09 | $114K | — | Filing → |
| RYTM | SELL | 2024-09-11 | $2.0M | — | Filing → |